US Patent Issued to UIF (University Industry Foundation), Yonsei University, OSONG MEDICAL INNOVATION FOUNDATION on April 21 for "Antibody specifically binding to PTK7 and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,433, issued on April 21, was assigned to UIF (University Industry Foundation), Yonsei University (Seoul, South Korea) and OSONG MEDICAL INNOVATION FOUNDATION (Chungcheongbuk-do, South Korea).

"Antibody specifically binding to PTK7 and use thereof" was invented by Seung Taek Lee (Seoul, South Korea), Won Sik Shin (Seoul, South Korea), Si Won Oh (Gyeonggi-do, South Korea), So Young Choi (Sejong-si, South Korea), Se Ra Lee (Sejong-si, South Korea) and So Ra Park (Chungcheongbuk-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Proposed are antibodies specifically binding to PTK7 and a use thereof and, more particularly, PTK7 neutralizing ...